Filing Details
- Accession Number:
- 0001104659-18-033905
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-16 19:49:56
- Reporting Period:
- 2018-05-14
- Accepted Time:
- 2018-05-16 19:49:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1660719 | Aralez Pharmaceuticals Inc. | ARLZ | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1527710 | Patrick James Tursi | C/O Aralez Pharmaceuticals Inc., 7100 West Credit Avenue, Suite 101 Mississauga A6 L5N 0E4 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, Without Par Value | Disposition | 2018-05-14 | 9,348 | $0.52 | 242,052 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 27,730 restricted stock units, which were previously granted on May 11, 2017 and which vested on May 11, 2018.
- This transaction was executed in multiple trades at prices ranging from $0.5206 to $0.5269. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
